Overview

D-dimer to Guide Anticoagulation Therapy in Patients With Atrial Fibrillation

Status:
Unknown status
Trial end date:
2020-05-30
Target enrollment:
Participant gender:
Summary
This was a prospective, three arms, randomized controlled study.
Phase:
N/A
Details
Lead Sponsor:
Wuhan Asia Heart Hospital
Treatments:
Dabigatran
Fibrin fragment D
Warfarin